Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-04

Clinical Trial Update: The Effect of Omalizumab on Responses to Cat Allergen Challenge [NA]

View source ↗

Summary

This clinical trial evaluated whether omalizumab modulates responses to cat allergen exposure in individuals with allergic rhinitis; the study has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omalizumab (Omalizumab)

Snippet

Sponsor: Johns Hopkins University | Conditions: Allergic Rhinitis | NA | Status: COMPLETED | Results posted: 2017-04-04